tromethamine has been researched along with imatinib mesylate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altintas, L; Degim, IT; Demirbolat, GM; Yilmaz, S | 1 |
| Altıntaş, L; Arsoy, T; Çoban, Ö; Değim, Z; Sözmen, M; Yılmaz, Ş | 1 |
2 other study(ies) available for tromethamine and imatinib mesylate
| Article | Year |
|---|---|
Development of Orally Applicable, Combinatorial Drug-Loaded Nanoparticles for the Treatment of Fibrosarcoma.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Caco-2 Cells; Chitosan; Drug Compounding; Drug Delivery Systems; Fibrosarcoma; Humans; Imatinib Mesylate; Ketoprofen; Male; Mice, Inbred BALB C; Nanocapsules; Tromethamine | 2018 |
Efficacy of targeted liposomes and nanocochleates containing imatinib plus dexketoprofen against fibrosarcoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Caco-2 Cells; Cell Proliferation; Cell Survival; Drug Compounding; Fibrosarcoma; Humans; Imatinib Mesylate; Ketoprofen; Liposomes; Male; Mice; Nanoparticles; Particle Size; Tromethamine; Xenograft Model Antitumor Assays | 2019 |